
|Articles|October 3, 2006
Topical steroids still best for treatment of intertriginous psoriasis
Bochum, Germany - Results of a study conducted by researchers at Ruhr University here suggest that an anti-inflammatory drug may help in treating intertriginous psoriasis.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Dual-Action Microneedle Patch Shows Promise for Psoriasis in Preclinical Study
3
AI Analysis Reveals Menopausal Hair Loss Linked to Systemic Health and Inflammation
4
Novel Botanical Moisturizer Demonstrates Superior Efficacy Over Metronidazole in Phase 2 Rosacea Trial
5














